Charles W Newhall III
Director at Supernus Pharmaceuticals, Inc. (SUPN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 10SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 23,800105,844 held (−18%) | $50.73 | $1.2M | -25.3% |
| Oct 10SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 1,200104,644 held (−1%) | $51.55 | $62K | -26.5% |
- Sell
Director Charles W Newhall III sold $1.2M of SUPN at $50.73 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Charles W Newhall III sold $62K of SUPN at $51.55 — pre-scheduled 10b5-1 plan sale.